HCW Biologics Other Current Liabilities

As of the most recent data (June 2026), HCWB shows a other current liabilities of $1.1M. That compares with $1.1M in the prior-year period — up 5.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HCWB's other current liabilities is now $1.1M (was $1.1M) — a 5.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether HCW Biologics is outperforming or lagging.

Tracking HCWB's other current liabilities over time shows whether HCW Biologics is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1M That compares with $1.1M in the prior-year period — up 5.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has HCW Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $1.1M) with ownership activity and broader fundamentals.

HCW Biologics's other current liabilities is $1.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.